This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devergne, O.
Right arrow Articles by Mosialos, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devergne, O.
Right arrow Articles by Mosialos, G.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Dec 1996, 7098-7108, Vol 16, No. 12
Copyright © 1996, American Society for Microbiology

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

O Devergne, E Hatzivassiliou, KM Izumi, KM Kaye, MF Kleijnen, E Kieff and G Mosialos
Department of Microbiology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

The Epstein-Barr virus (EBV) transforming protein LMP1 appears to be a constitutively activated tumor necrosis factor receptor (TNFR) on the basis of an intrinsic ability to aggregate in the plasma membrane and an association of its cytoplasmic carboxyl terminus (CT) with TNFR- associated factors (TRAFs). We now show that in EBV-transformed B lymphocytes most of TRAF1 or TRAF3 and 5% of TRAF2 are associated with LMP1 and that most of LMP1 is associated with TRAF1 or TRAF3. TRAF1, TRAF2, and TRAF3 bind to a single site in the LMP1 CT corresponding to amino acids (aa) 199 to 214, within a domain which is important for B- lymphocyte growth transformation (aa 187 to 231). Further deletional and alanine mutagenesis analyses and comparison with TRAF binding sequences in CD40, in CD30, and in the LMP1 of other lymphycryptoviruses provide the first evidence that PXQXT/S is a core TRAF binding motif. The negative effects of point mutations in the LMP1(1-231) core TRAF binding motif on TRAF binding and NF-kappaB activation genetically link the TRAFs to LMP1(1-231)-mediated NF-kappaB activation. NF-kappaB activation by LMP1(1-231) is likely to be mediated by TRAF1/TRAF2 heteroaggregates since TRAF1 is unique among the TRAFs in coactivating NF-kappaB with LMP1(1-231), a TRAF2 dominant- negative mutant can block LMP1(1-231)-mediated NF-kappaB activation as well as TRAF1 coactivation, and 30% of TRAF2 is associated with TRAF1 in EBV-transformed B cells. TRAF3 is a negative modulator of LMP1(1- 231)-mediated NF-kappaB activation. Surprisingly, TRAF1, -2, or -3 does not interact with the terminal LMP1 CT aa 333 to 386 which can independently mediate NF-kappaB activation. The constitutive association of TRAFs with LMP1 through the aa 187 to 231 domain which is important in NF-kappaB activation and primary B-lymphocyte growth transformation implicates TRAF aggregation in LMP1 signaling.


This article has been cited by other articles:

  • Everly, D. N. Jr., Mainou, B. A., Raab-Traub, N. (2009). Transcriptional Downregulation of p27KIP1 through Regulation of E2F Function during LMP1-Mediated Transformation. J. Virol. 83: 12671-12679 [Abstract] [Full Text]  
  • Graham, J. P., Moore, C. R., Bishop, G. A. (2009). Roles of the TRAF2/3 Binding Site in Differential B Cell Signaling by CD40 and Its Viral Oncogenic Mimic, LMP1. J. Immunol. 183: 2966-2973 [Abstract] [Full Text]  
  • Vaysberg, M., Hatton, O., Lambert, S. L., Snow, A. L., Wong, B., Krams, S. M., Martinez, O. M. (2008). Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos. J. Biol. Chem. 283: 36573-36585 [Abstract] [Full Text]  
  • Song, Y.-J., Izumi, K. M., Shinners, N. P., Gewurz, B. E., Kieff, E. (2008). IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. Proc. Natl. Acad. Sci. USA 105: 18448-18453 [Abstract] [Full Text]  
  • Chen, Y.-R., Liu, M.-T., Chang, Y.-T., Wu, C.-C., Hu, C.-Y., Chen, J.-Y. (2008). Epstein-Barr Virus Latent Membrane Protein 1 Represses DNA Repair through the PI3K/Akt/FOXO3a Pathway in Human Epithelial Cells. J. Virol. 82: 8124-8137 [Abstract] [Full Text]  
  • Ikeda, O., Sekine, Y., Yasui, T., Oritani, K., Sugiyma, K., Muromoto, R., Ohbayashi, N., Yoshimura, A., Matsuda, T. (2008). STAP-2 Negatively Regulates both Canonical and Noncanonical NF-{kappa}B Activation Induced by Epstein-Barr Virus-Derived Latent Membrane Protein 1. Mol. Cell. Biol. 28: 5027-5042 [Abstract] [Full Text]  
  • Guasparri, I., Bubman, D., Cesarman, E. (2008). EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111: 3813-3820 [Abstract] [Full Text]  
  • Cameron, J. E., Yin, Q., Fewell, C., Lacey, M., McBride, J., Wang, X., Lin, Z., Schaefer, B. C., Flemington, E. K. (2008). Epstein-Barr Virus Latent Membrane Protein 1 Induces Cellular MicroRNA miR-146a, a Modulator of Lymphocyte Signaling Pathways. J. Virol. 82: 1946-1958 [Abstract] [Full Text]  
  • Lambert, S. L., Martinez, O. M. (2007). Latent Membrane Protein 1 of EBV Activates Phosphatidylinositol 3-Kinase to Induce Production of IL-10. J. Immunol. 179: 8225-8234 [Abstract] [Full Text]  
  • Mainou, B. A., Everly, D. N. Jr., Raab-Traub, N. (2007). Unique Signaling Properties of CTAR1 in LMP1-Mediated Transformation. J. Virol. 81: 9680-9692 [Abstract] [Full Text]  
  • Zou, P., Kawada, J., Pesnicak, L., Cohen, J. I. (2007). Bortezomib Induces Apoptosis of Epstein-Barr Virus (EBV)-Transformed B Cells and Prolongs Survival of Mice Inoculated with EBV-Transformed B Cells. J. Virol. 81: 10029-10036 [Abstract] [Full Text]  
  • Charalambous, C. T., Hannigan, A., Tsimbouri, P., McPhee, G. M., Wilson, J. B. (2007). Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF{alpha} prior to neoplasia. Carcinogenesis 28: 1839-1848 [Abstract] [Full Text]  
  • Lu, L.-F., Ahonen, C. L., Lind, E. F., Raman, V. S., Cook, W. J., Lin, L.-L., Noelle, R. J. (2007). The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation. Blood 110: 193-200 [Abstract] [Full Text]  
  • Garcia, M. I., Kaserman, J., Chung, Y.-H., Jung, J. U., Lee, S.-H. (2007). Herpesvirus Saimiri STP-A Oncoprotein Utilizes Src Family Protein Tyrosine Kinase and Tumor Necrosis Factor Receptor-Associated Factors To Elicit Cellular Signal Transduction. J. Virol. 81: 2663-2674 [Abstract] [Full Text]  
  • Tsai, C.-L., Li, H.-P., Lu, Y.-J., Hsueh, C., Liang, Y., Chen, C.-L., Tsao, S. W., Tse, K.-P., Yu, J.-S., Chang, Y.-S. (2006). Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling. Cancer Res. 66: 11668-11676 [Abstract] [Full Text]  
  • Geiger, T. R., Martin, J. M. (2006). The Epstein-Barr Virus-Encoded LMP-1 Oncoprotein Negatively Affects Tyk2 Phosphorylation and Interferon Signaling in Human B Cells. J. Virol. 80: 11638-11650 [Abstract] [Full Text]  
  • Soni, V., Yasui, T., Cahir-McFarland, E., Kieff, E. (2006). LMP1 Transmembrane Domain 1 and 2 (TM1-2) FWLY Mediates Intermolecular Interactions with TM3-6 To Activate NF-{kappa}B. J. Virol. 80: 10787-10793 [Abstract] [Full Text]  
  • Snow, A. L., Lambert, S. L., Natkunam, Y., Esquivel, C. O., Krams, S. M., Martinez, O. M. (2006). EBV Can Protect Latently Infected B Cell Lymphomas from Death Receptor-Induced Apoptosis.. J. Immunol. 177: 3283-3293 [Abstract] [Full Text]  
  • Mainou, B. A., Raab-Traub, N. (2006). LMP1 Strain Variants: Biological and Molecular Properties.. J. Virol. 80: 6458-6468 [Abstract] [Full Text]  
  • Brinkmann, M. M., Schulz, T. F. (2006). Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.. J. Gen. Virol. 87: 1047-1074 [Abstract] [Full Text]  
  • Xie, P., Hostager, B. S., Munroe, M. E., Moore, C. R., Bishop, G. A. (2006). Cooperation between TNF Receptor-Associated Factors 1 and 2 in CD40 Signaling. J. Immunol. 176: 5388-5400 [Abstract] [Full Text]  
  • Ordway, D., Harton, M., Henao-Tamayo, M., Montoya, R., Orme, I. M., Gonzalez-Juarrero, M. (2006). Enhanced Macrophage Activity in Granulomatous Lesions of Immune Mice Challenged with Mycobacterium tuberculosis.. J. Immunol. 176: 4931-4939 [Abstract] [Full Text]  
  • Keller, S. A., Hernandez-Hopkins, D., Vider, J., Ponomarev, V., Hyjek, E., Schattner, E. J., Cesarman, E. (2006). NF-{kappa}B is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood 107: 3295-3302 [Abstract] [Full Text]  
  • Heinemann, S., Biesinger, B., Fleckenstein, B., Albrecht, J.-C. (2006). NF{kappa}B Signaling Is Induced by the Oncoprotein Tio through Direct Interaction with TRAF6. J. Biol. Chem. 281: 8565-8572 [Abstract] [Full Text]  
  • Uemura, N., Kajino, T., Sanjo, H., Sato, S., Akira, S., Matsumoto, K., Ninomiya-Tsuji, J. (2006). TAK1 Is a Component of the Epstein-Barr Virus LMP1 Complex and Is Essential for Activation of JNK but Not of NF-{kappa}B. J. Biol. Chem. 281: 7863-7872 [Abstract] [Full Text]  
  • Song, Y.-J., Jen, K.-Y., Soni, V., Kieff, E., Cahir-McFarland, E. (2006). IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-{kappa}B activation. Proc. Natl. Acad. Sci. USA 103: 2689-2694 [Abstract] [Full Text]  
  • Wu, L., Nakano, H., Wu, Z. (2006). The C-terminal Activating Region 2 of the Epstein-Barr Virus-encoded Latent Membrane Protein 1 Activates NF-{kappa}B through TRAF6 and TAK1. J. Biol. Chem. 281: 2162-2169 [Abstract] [Full Text]  
  • Kashuba, E. V., Gradin, K., Isaguliants, M., Szekely, L., Poellinger, L., Klein, G., Kazlauskas, A. (2006). Regulation of Transactivation Function of the Aryl Hydrocarbon Receptor by the Epstein-Barr Virus-encoded EBNA-3 Protein. J. Biol. Chem. 281: 1215-1223 [Abstract] [Full Text]  
  • Chuang, H.-C., Lay, J.-D., Hsieh, W.-C., Wang, H.-C., Chang, Y., Chuang, S.-E., Su, I.-J. (2005). Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 106: 3090-3096 [Abstract] [Full Text]  
  • Wu, S., Xie, P., Welsh, K., Li, C., Ni, C.-Z., Zhu, X., Reed, J. C., Satterthwait, A. C., Bishop, G. A., Ely, K. R. (2005). LMP1 Protein from the Epstein-Barr Virus Is a Structural CD40 Decoy in B Lymphocytes for Binding to TRAF3. J. Biol. Chem. 280: 33620-33626 [Abstract] [Full Text]  
  • Ordway, D., Henao-Tamayo, M., Orme, I. M., Gonzalez-Juarrero, M. (2005). Foamy Macrophages within Lung Granulomas of Mice Infected with Mycobacterium tuberculosis Express Molecules Characteristic of Dendritic Cells and Antiapoptotic Markers of the TNF Receptor-Associated Factor Family. J. Immunol. 175: 3873-3881 [Abstract] [Full Text]  
  • Lu, K. T., Dryer, R. L., Song, C., Covey, L. R. (2005). Maintenance of the CD40-related immunodeficient response in hyper-IgM B cells immortalized with a LMP1-regulated mini-EBV. J. Leukoc. Biol. 78: 620-629 [Abstract] [Full Text]  
  • Douglas, K. M. J., Raza, K., Stevens, R., Erb, N., Jones, E. L., Kitas, G. D. (2005). Bronchial MALT lymphoma in longstanding rheumatoid arthritis. Rheumatology (Oxford) 44: 687-689 [Full Text]  
  • Hauer, J., Puschner, S., Ramakrishnan, P., Simon, U., Bongers, M., Federle, C., Engelmann, H. (2005). TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-{kappa}B pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. USA 102: 2874-2879 [Abstract] [Full Text]  
  • Xie, P., Bishop, G. A. (2004). Roles of TNF Receptor-Associated Factor 3 in Signaling to B Lymphocytes by Carboxyl-Terminal Activating Regions 1 and 2 of the EBV-Encoded Oncoprotein Latent Membrane Protein 1. J. Immunol. 173: 5546-5555 [Abstract] [Full Text]  
  • Roychowdhury, S., Baiocchi, R. A., Vourganti, S., Bhatt, D., Blaser, B. W., Freud, A. G., Chou, J., Chen, C.-S., Xiao, J. J., Parthun, M., Chan, K. K., Eisenbeis, C. F., Ferketich, A. K., Grever, M. R., Chen, C.-S., Caligiuri, M. A. (2004). Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus-Positive Lymphoproliferative Disorder. JNCI J Natl Cancer Inst 96: 1447-1457 [Abstract] [Full Text]  
  • Burgess, S. C., Young, J. R., Baaten, B. J. G., Hunt, L., Ross, L. N. J., Parcells, M. S., Kumar, P. M., Tregaskes, C. A., Lee, L. F., Davison, T. F. (2004). Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc. Natl. Acad. Sci. USA 101: 13879-13884 [Abstract] [Full Text]  
  • Lin, J.-C., Cherng, J.-M., Lin, H.-J., Tsang, C.-W., Liu, Y.-X., Lee, S. P. (2004). Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'. J. Gen. Virol. 85: 2023-2034 [Abstract] [Full Text]  
  • Gil, J., Garcia, M. A., Gomez-Puertas, P., Guerra, S., Rullas, J., Nakano, H., Alcami, J., Esteban, M. (2004). TRAF Family Proteins Link PKR with NF-{kappa}B Activation. Mol. Cell. Biol. 24: 4502-4512 [Abstract] [Full Text]  
  • Sorokina, E. M., Merlo, J. J. Jr., Tsygankov, A. Y. (2004). Molecular Mechanisms of the Effect of Herpesvirus saimiri Protein StpC on the Signaling Pathway Leading to NF-{kappa}B Activation. J. Biol. Chem. 279: 13469-13477 [Abstract] [Full Text]  
  • Xie, P., Hostager, B. S., Bishop, G. A. (2004). Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes. JEM 199: 661-671 [Abstract] [Full Text]  
  • D'Souza, B. N., Edelstein, L. C., Pegman, P. M., Smith, S. M., Loughran, S. T., Clarke, A., Mehl, A., Rowe, M., Gelinas, C., Walls, D. (2004). Nuclear Factor {kappa}B-Dependent Activation of the Antiapoptotic bfl-1 Gene by the Epstein-Barr Virus Latent Membrane Protein 1 and Activated CD40 Receptor. J. Virol. 78: 1800-1816 [Abstract] [Full Text]  
  • Thompson, M. P., Kurzrock, R. (2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res. 10: 803-821 [Abstract] [Full Text]  
  • Edwards, R. H., Sitki-Green, D., Moore, D. T., Raab-Traub, N. (2004). Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma. J. Virol. 78: 868-881 [Abstract] [Full Text]  
  • Luftig, M., Yasui, T., Soni, V., Kang, M.-S., Jacobson, N., Cahir-McFarland, E., Seed, B., Kieff, E. (2004). Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK{alpha}-dependent noncanonical NF-{kappa}B activation. Proc. Natl. Acad. Sci. USA 101: 141-146 [Abstract] [Full Text]  
  • Yasui, T., Luftig, M., Soni, V., Kieff, E. (2004). Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling. Proc. Natl. Acad. Sci. USA 101: 278-283 [Abstract] [Full Text]  
  • Luftig, M., Prinarakis, E., Yasui, T., Tsichritzis, T., Cahir-McFarland, E., Inoue, J.-I., Nakano, H., Mak, T. W., Yeh, W.-C., Li, X., Akira, S., Suzuki, N., Suzuki, S., Mosialos, G., Kieff, E. (2003). Epstein-Barr virus latent membrane protein 1 activation of NF-{kappa}B through IRAK1 and TRAF6. Proc. Natl. Acad. Sci. USA 100: 15595-15600 [Abstract] [Full Text]  
  • Atkinson, P. G. P., Coope, H. J., Rowe, M., Ley, S. C. (2003). Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-{kappa}B2 p100 to p52. J. Biol. Chem. 278: 51134-51142 [Abstract] [Full Text]  
  • Tellam, J., Connolly, G., Webb, N., Duraiswamy, J., Khanna, R. (2003). Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity. Blood 102: 4535-4540 [Abstract] [Full Text]  
  • Tang, W., Pavlish, O. A., Spiegelman, V. S., Parkhitko, A. A., Fuchs, S. Y. (2003). Interaction of Epstein-Barr Virus Latent Membrane Protein 1 with SCFHOS/{beta}-TrCP E3 Ubiquitin Ligase Regulates Extent of NF-{kappa}B Activation. J. Biol. Chem. 278: 48942-48949 [Abstract] [Full Text]  
  • Saito, N., Courtois, G., Chiba, A., Yamamoto, N., Nitta, T., Hironaka, N., Rowe, M., Yamamoto, N., Yamaoka, S. (2003). Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-{kappa}B through Distinct Signaling Pathways in Fibroblast Cell Lines. J. Biol. Chem. 278: 46565-46575 [Abstract] [Full Text]  
  • He, B., Raab-Traub, N., Casali, P., Cerutti, A. (2003). EBV-Encoded Latent Membrane Protein 1 Cooperates with BAFF/BLyS and APRIL to Induce T Cell-Independent Ig Heavy Chain Class Switching. J. Immunol. 171: 5215-5224 [Abstract] [Full Text]  
  • Geimonen, E., Fernandez, I., Gavrilovskaya, I. N., Mackow, E. R. (2003). Tyrosine Residues Direct the Ubiquitination and Degradation of the NY-1 Hantavirus G1 Cytoplasmic Tail. J. Virol. 77: 10760-10868 [Abstract] [Full Text]  
  • Brinkmann, M. M., Glenn, M., Rainbow, L., Kieser, A., Henke-Gendo, C., Schulz, T. F. (2003). Activation of Mitogen-Activated Protein Kinase and NF-{kappa}B Pathways by a Kaposi's Sarcoma-Associated Herpesvirus K15 Membrane Protein. J. Virol. 77: 9346-9358 [Abstract] [Full Text]  
  • Dudziak, D., Kieser, A., Dirmeier, U., Nimmerjahn, F., Berchtold, S., Steinkasserer, A., Marschall, G., Hammerschmidt, W., Laux, G., Bornkamm, G. W. (2003). Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-{kappa}B Signaling Pathway. J. Virol. 77: 8290-8298 [Abstract] [Full Text]  
  • Siegler, G, Kremmer, E, Gonnella, R, Niedobitek, G (2003). Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma. Mol. Pathol. 56: 156-161 [Abstract] [Full Text]  
  • Dirmeier, U., Neuhierl, B., Kilger, E., Reisbach, G., Sandberg, M. L., Hammerschmidt, W. (2003). Latent Membrane Protein 1 Is Critical for Efficient Growth Transformation of Human B Cells by Epstein-Barr Virus. Cancer Res. 63: 2982-2989 [Abstract] [Full Text]  
  • Loomis, R., Carbone, R., Reiss, M., Lacy, J. (2003). Bcl-2 Antisense (G3139, Genasense) Enhances the in Vitro and in Vivo Response of Epstein-Barr Virus-associated Lymphoproliferative Disease to Rituximab. Clin. Cancer Res. 9: 1931-1939 [Abstract] [Full Text]  
  • Prince, S., Keating, S., Fielding, C., Brennan, P., Floettmann, E., Rowe, M. (2003). Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different Mechanisms. J. Virol. 77: 5000-5007 [Abstract] [Full Text]  
  • Chen, H., Hutt-Fletcher, L., Cao, L., Hayward, S. D. (2003). A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus. J. Virol. 77: 4139-4148 [Abstract] [Full Text]  
  • Eliopoulos, A. G., Waites, E. R., Blake, S. M. S., Davies, C., Murray, P., Young, L. S. (2002). TRAF1 Is a Critical Regulator of JNK Signaling by the TRAF-Binding Domain of the Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1 but Not CD40. J. Virol. 77: 1316-1328 [Abstract] [Full Text]  
  • Geimonen, E., LaMonica, R., Springer, K., Farooqui, Y., Gavrilovskaya, I. N., Mackow, E. R. (2002). Hantavirus Pulmonary Syndrome-Associated Hantaviruses Contain Conserved and Functional ITAM Signaling Elements. J. Virol. 77: 1638-1643 [Abstract] [Full Text]  
  • Munzert, G., Kirchner, D., Stobbe, H., Bergmann, L., Schmid, R. M., Dohner, H., Heimpel, H. (2002). Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis. Blood 100: 3749-3756 [Abstract] [Full Text]  
  • Tsai, C.-N., Tsai, C.-L., Tse, K.-P., Chang, H.-Y., Chang, Y.-S. (2002). The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl. Acad. Sci. USA 99: 10084-10089 [Abstract] [Full Text]  
  • Bishop, G. A., Hostager, B. S., Brown, K. D. (2002). Mechanisms of TNF receptor-associated factor (TRAF) regulation in B lymphocytes. J. Leukoc. Biol. 72: 19-23 [Abstract] [Full Text]  
  • Hay, S., Kannourakis, G. (2002). A time to kill: viral manipulation of the cell death program. J. Gen. Virol. 83: 1547-1564 [Abstract] [Full Text]  
  • Brown, K. D., Hostager, B. S., Bishop, G. A. (2002). Regulation of TRAF2 Signaling by Self-induced Degradation. J. Biol. Chem. 277: 19433-19438 [Abstract] [Full Text]  
  • Han, I., Xue, Y., Harada, S., Orstavik, S., Skalhegg, B., Kieff, E. (2002). Protein Kinase A Associates with HA95 and Affects Transcriptional Coactivation by Epstein-Barr Virus Nuclear Proteins. Mol. Cell. Biol. 22: 2136-2146 [Abstract] [Full Text]  
  • Eliopoulos, A. G., Davies, C., Blake, S. S. M., Murray, P., Najafipour, S., Tsichlis, P. N., Young, L. S. (2002). The Oncogenic Protein Kinase Tpl-2/Cot Contributes to Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1-Induced NF-{kappa}B Signaling Downstream of TRAF2. J. Virol. 76: 4567-4579 [Abstract] [Full Text]  
  • Prokova, V., Mosialos, G., Kardassis, D. (2002). Inhibition of Transforming Growth Factor beta Signaling and Smad-dependent Activation of Transcription by the Latent Membrane Protein 1 of Epstein-Barr Virus. J. Biol. Chem. 277: 9342-9350 [Abstract] [Full Text]  
  • Xia, P., Wang, L., Moretti, P. A. B., Albanese, N., Chai, F., Pitson, S. M., D'Andrea, R. J., Gamble, J. R., Vadas, M. A. (2002). Sphingosine Kinase Interacts with TRAF2 and Dissects Tumor Necrosis Factor-alpha Signaling. J. Biol. Chem. 277: 7996-8003 [Abstract] [Full Text]  
  • Higuchi, M., Kieff, E., Izumi, K. M. (2002). The Epstein-Barr Virus Latent Membrane Protein 1 Putative Janus Kinase 3 (JAK3) Binding Domain Does Not Mediate JAK3 Association or Activation in B-Lymphoma or Lymphoblastoid Cell Lines. J. Virol. 76: 455-459 [Abstract] [Full Text]  
  • Zhang, L., Wu, L., Hong, K., Pagano, J. S. (2001). Intracellular Signaling Molecules Activated by Epstein-Barr Virus for Induction of Interferon Regulatory Factor 7. J. Virol. 75: 12393-12401 [Abstract] [Full Text]  
  • Busch, L. K., Bishop, G. A. (2001). Multiple Carboxyl-Terminal Regions of the EBV Oncoprotein, Latent Membrane Protein 1, Cooperatively Regulate Signaling to B Lymphocytes Via TNF Receptor-Associated Factor (TRAF)-Dependent and TRAF-Independent Mechanisms. J. Immunol. 167: 5805-5813 [Abstract] [Full Text]  
  • Fielding, C. A., Sandvej, K., Mehl, A., Brennan, P., Jones, M., Rowe, M. (2001). Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling Pathways. J. Virol. 75: 9129-9141 [Abstract] [Full Text]  
  • Groves, A. K., Cotter, M. A., Subramanian, C., Robertson, E. S. (2001). The Latency-Associated Nuclear Antigen Encoded by Kaposi's Sarcoma-Associated Herpesvirus Activates Two Major Essential Epstein-Barr Virus Latent Promoters. J. Virol. 75: 9446-9457 [Abstract] [Full Text]  
  • Portis, T., Harding, J. C., Ratner, L. (2001). The contribution of NF-{kappa}B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood 98: 1200-1208 [Abstract] [Full Text]  
  • Shirakata, M., Imadome, K.-I., Okazaki, K., Hirai, K. (2001). Activation of TRAF5 and TRAF6 Signal Cascades Negatively Regulates the Latent Replication Origin of Epstein-Barr Virus through p38 Mitogen-Activated Protein Kinase. J. Virol. 75: 5059-5068 [Abstract] [Full Text]  
  • Murono, S., Inoue, H., Tanabe, T., Joab, I., Yoshizaki, T., Furukawa, M., Pagano, J. S. (2001). Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. USA 10.1073/pnas.121016998v1 [Abstract] [Full Text]  
  • Brown, K. D., Hostager, B. S., Bishop, G. A. (2001). Differential Signaling and Tumor Necrosis Factor Receptor-Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1). JEM 193: 943-954 [Abstract] [Full Text]  
  • Higuchi, M., Izumi, K. M., Kieff, E. (2001). Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: Protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA 98: 4675-4680 [Abstract] [Full Text]  
  • Chen, H., Lee, J. M., Zong, Y., Borowitz, M., Ng, M. H., Ambinder, R. F., Hayward, S. D. (2001). Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors. J. Virol. 75: 2929-2937 [Abstract] [Full Text]  
  • Hör, S., Ensser, A., Reiss, C., Ballmer-Hofer, K., Biesinger, B. (2001). Herpesvirus saimiri protein StpB associates with cellular Src. J. Gen. Virol. 82: 339-344 [Abstract] [Full Text]  
  • Cho, Y.-G., Ramer, J., Rivailler, P., Quink, C., Garber, R. L., Beier, D. R., Wang, F. (2001). An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc. Natl. Acad. Sci. USA 98: 1224-1229 [Abstract] [Full Text]  
  • Zhang, L., Pagano, J. S. (2001). Interferon Regulatory Factor 7 Mediates Activation of Tap-2 by Epstein-Barr Virus Latent Membrane Protein 1. J. Virol. 75: 341-350 [Abstract] [Full Text]  
  • Sandberg, M. L., Kaykas, A., Sugden, B. (2000). Latent Membrane Protein 1 of Epstein-Barr Virus Inhibits as Well as Stimulates Gene Expression. J. Virol. 74: 9755-9761 [Abstract] [Full Text]  
  • Annunziata, C. M., Safiran, Y. J., Irving, S. G., Kasid, U. N., Cossman, J. (2000). Hodgkin disease: pharmacologic intervention of the CD40-NFkappa B pathway by a protease inhibitor. Blood 96: 2841-2848 [Abstract] [Full Text]  
  • Nicholas, J (2000). Evolutionary aspects of oncogenic herpesviruses. Mol. Pathol. 53: 222-237 [Abstract] [Full Text]  
  • Young, L S, Dawson, C W, Eliopoulos, A G (2000). The expression and function of Epstein-Barr virus encoded latent genes. Mol. Pathol. 53: 238-247 [Abstract] [Full Text]  
  • Sandvej, K, Andresen, B S, Zhou, X-G, Gregersen, N, Hamilton-Dutoit, S (2000). Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site. Mol. Pathol. 53: 280-288 [Abstract] [Full Text]  
  • Keller, S. A., Schattner, E. J., Cesarman, E. (2000). Inhibition of NF-kappa B induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96: 2537-2542 [Abstract] [Full Text]  
  • Webster-Cyriaque, J., Middeldorp, J., Raab-Traub, N. (2000). Hairy Leukoplakia: an Unusual Combination of Transforming and Permissive Epstein-Barr Virus Infections. J. Virol. 74: 7610-7618 [Abstract] [Full Text]  
  • Eliopoulos, A. G., Davies, C., Knox, P. G., Gallagher, N. J., Afford, S. C., Adams, D. H., Young, L. S. (2000). CD40 Induces Apoptosis in Carcinoma Cells through Activation of Cytotoxic Ligands of the Tumor Necrosis Factor Superfamily. Mol. Cell. Biol. 20: 5503-5515 [Abstract] [Full Text]  
  • Hatzoglou, A., Roussel, J., Bourgeade, M.-F., Rogier, E., Madry, C., Inoue, J., Devergne, O., Tsapis, A. (2000). TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-{kappa}B, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase. J. Immunol. 165: 1322-1330 [Abstract] [Full Text]  
  • Flavell, J R, Baumforth, K R N, Williams, D M, Lukesova, M, Madarova, J, Noskova, V, Prochazkova, J, Lowe, D, Kolar, Z, Murray, P G, Nelson, P N (2000). Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status. Mol. Pathol. 53: 145-149 [Abstract] [Full Text]  
  • Murono, S., Yoshizaki, T., Sato, H., Takeshita, H., Furukawa, M., Pagano, J. S. (2000). Aspirin Inhibits Tumor Cell Invasiveness Induced by Epstein-Barr Virus Latent Membrane Protein 1 through Suppression of Matrix Metalloproteinase-9 Expression. Cancer Res. 60: 2555-2561 [Abstract] [Full Text]  
  • Damania, B., DeMaria, M., Jung, J. U., Desrosiers, R. C. (2000). Activation of Lymphocyte Signaling by the R1 Protein of Rhesus Monkey Rhadinovirus. J. Virol. 74: 2721-2730 [Abstract] [Full Text]  
  • Feuillard, J., Schuhmacher, M., Kohanna, S., Asso-Bonnet, M., Ledeur, F., Joubert-Caron, R., Bissieres, P., Polack, A., Bornkamm, G. W., Raphael, M. (2000). Inducible loss of NF-kappa B activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 95: 2068-2075 [Abstract] [Full Text]  
  • Xu, J., Ahmad, A., D'Addario, M., Knafo, L., Jones, J. F., Prasad, U., Dolcetti, R., Vaccher, E., Menezes, J. (2000). Analysis and Significance of Anti-Latent Membrane Protein-1 Antibodies in the Sera of Patients with EBV-Associated Diseases. J. Immunol. 164: 2815-2822 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»